Tag #R&D

Showing 1 to 10 of 10 results

euronews.com

🌐 85% Global Worthiness

Sep 16, 16:19

Global Innovation Index 2025: Switzerland Leads, China Enters Top 10

The 2025 Global Innovation Index ranks Switzerland first, Sweden second, and the United States third, with China entering the top 10 for the first time, displacing Germany, while overall innovation investment slows.

Global Innovation Index 2025: Switzerland Leads, China Enters Top 10

The 2025 Global Innovation Index ranks Switzerland first, Sweden second, and the United States third, with China entering the top 10 for the first time, displacing Germany, while overall innovation investment slows.

Progress

16% Bias Score

ShareSaveArticle

Industry, Innovation, and Infrastructure

12345678

Previous 1 of 8 Next

What are some notable technological advancements highlighted in the report, and what are their broader implications?

The report highlights advancements in green supercomputing, falling battery prices accelerating clean energy transition, the rise of electric vehicles, 5G availability in half the world, and falling genome sequencing costs enabling personalized medicine. However, it also notes a decline in drug approvals, suggesting uneven progress across sectors.

forbes.com

🌐 85% Global Worthiness

Aug 19, 22:17

OBBAA's R&D Tax Break Exacerbates U.S. Tech Labor Shortage

The One Big Beautiful Bill Act revived a tax break for immediate deduction of R&D costs, increasing demand for U.S. tech labor by 15-20% and wages by 20-25% in one month, but immigration restrictions limit supply, creating a labor shortage and potentially hindering innovation.

OBBAA's R&D Tax Break Exacerbates U.S. Tech Labor Shortage

The One Big Beautiful Bill Act revived a tax break for immediate deduction of R&D costs, increasing demand for U.S. tech labor by 15-20% and wages by 20-25% in one month, but immigration restrictions limit supply, creating a labor shortage and potentially hindering innovation.

Progress

56% Bias Score

ShareSaveArticle

Decent Work and Economic Growth

12345678

Previous 1 of 8 Next

How does the current immigration policy interact with the OBBAA's R&D tax incentives to shape the U.S. tech labor market?

The OBBAA's R&D tax break incentivizes domestic hiring but exacerbates existing talent scarcity due to immigration limitations. This creates a bidding war for engineers, potentially hindering innovation by increasing labor costs and slowing project timelines instead of accelerating them as intended.

welt.de

🌐 75% Global Worthiness

Apr 2, 16:09

Boehringer Ingelheim's 2024 Sales Surge Driven by Jardiance, but US Pricing and EU Regulations Pose Challenges

Boehringer Ingelheim reported €21.9 billion in human pharmaceutical sales in 2024, a 7% increase year-over-year, driven by Jardiance (€8.4 billion), while animal health sales reached €4.7 billion, with Nexgard (€1.35 billion) leading the growth; the company invested €6.2 billion in R&D and anticipat...

Boehringer Ingelheim's 2024 Sales Surge Driven by Jardiance, but US Pricing and EU Regulations Pose Challenges

Boehringer Ingelheim reported €21.9 billion in human pharmaceutical sales in 2024, a 7% increase year-over-year, driven by Jardiance (€8.4 billion), while animal health sales reached €4.7 billion, with Nexgard (€1.35 billion) leading the growth; the company invested €6.2 billion in R&D and anticipat...

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What were the key financial results for Boehringer Ingelheim in 2024, and what factors drove this performance?

Boehringer Ingelheim reported a 7% increase in human pharmaceutical sales to €21.9 billion in 2024, driven by a 14%+ surge in Jardiance sales to €8.4 billion. Animal health sales also grew by 1.9% to €4.7 billion, with Nexgard sales increasing by 14% to €1.35 billion. The company invested €6.2 billion in R&D, anticipating several new product launches, potentially two in 2025.

spanish.china.org.cn

🌐 85% Global Worthiness

Mar 26, 13:14

AstraZeneca Invests $2.5 Billion in China R&D Center

AstraZeneca is investing $2.5 billion in a new research and development center in Beijing, its sixth globally, to leverage China's growing pharmaceutical innovation and establish a key hub for global drug development, reflecting China's rising role in the industry and resulting in collaborations wit...

AstraZeneca Invests $2.5 Billion in China R&D Center

AstraZeneca is investing $2.5 billion in a new research and development center in Beijing, its sixth globally, to leverage China's growing pharmaceutical innovation and establish a key hub for global drug development, reflecting China's rising role in the industry and resulting in collaborations wit...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the significance of AstraZeneca's $2.5 billion investment in a new R&D center in Beijing?

AstraZeneca, a multinational pharmaceutical company, is significantly increasing its investment in research and development (R&D) in China, aiming to leverage the country's growing innovation capacity. This $2.5 billion investment will establish a sixth global R&D center in Beijing, focusing on initial research and clinical development, and includes collaborations with local partners.

elmundo.es

🌐 65% Global Worthiness

Dec 3, 22:11

Andalusia Launches New Law to Boost Science and Innovation

The Andalusian government approved a new law to promote science, technology, and innovation, including tax incentives for companies investing in R&D, researcher mobility programs, a European Research Coordination Office, and a new Andalusian System of Excellence Research (Saiex).

Andalusia Launches New Law to Boost Science and Innovation

The Andalusian government approved a new law to promote science, technology, and innovation, including tax incentives for companies investing in R&D, researcher mobility programs, a European Research Coordination Office, and a new Andalusian System of Excellence Research (Saiex).

Progress

44% Bias Score

ShareSaveArticle

12345678

Previous 1 of 8 Next

How will the new law improve collaboration between universities and businesses in Andalusia?

The overarching goal is to foster public-private collaboration, increase private investment in R&D, and improve the overall excellence of Andalusian research. The law will replace the 2007 version, aiming to attract and retain top scientific talent both domestically and internationally. This includes the creation of a new Andalusian System of Excellence Research (Saiex) to identify and certify top researchers and the Andalusian Institute of Advanced Research (I2A2) to attract talent.

usa.chinadaily.com.cn

🌐 85% Global Worthiness

Sep 5, 10:20

China's Innovation Clusters Top Global Rankings

The Shenzhen-Hong Kong-Guangzhou innovation cluster ranked first in the 2025 Global Innovation Index, marking China's highest number of clusters on the list (24) and highlighting the country's significant investment in R&D and strengthened IP protection.

China's Innovation Clusters Top Global Rankings

The Shenzhen-Hong Kong-Guangzhou innovation cluster ranked first in the 2025 Global Innovation Index, marking China's highest number of clusters on the list (24) and highlighting the country's significant investment in R&D and strengthened IP protection.

Progress

36% Bias Score

ShareSaveArticle

Industry, Innovation, and Infrastructure

12345678

Previous 1 of 8 Next

What is the primary reason for China's high ranking in global innovation clusters?

China's top ranking is attributed to its substantial investment in research and development (exceeding \$505 billion in 2024, an 8.3 percent increase from the previous year) and improvements in its intellectual property protection environment.

usa.chinadaily.com.cn

🌐 85% Global Worthiness

Jun 13, 07:12

China Showcases Tech Prowess, Pledges Deeper EU Collaboration at VivaTech 2025

At VivaTech 2025 in Paris, China's increased investment in R\&D (\$500 billion in 2024) and participation in over 300 joint EU Horizon 2020 projects highlighted its commitment to international science and technology collaboration, showcasing advancements in AI, robotics, and smart mobility.

China Showcases Tech Prowess, Pledges Deeper EU Collaboration at VivaTech 2025

At VivaTech 2025 in Paris, China's increased investment in R\&D (\$500 billion in 2024) and participation in over 300 joint EU Horizon 2020 projects highlighted its commitment to international science and technology collaboration, showcasing advancements in AI, robotics, and smart mobility.

Progress

32% Bias Score

ShareSaveArticle

Industry, Innovation, and Infrastructure

12345678

Previous 1 of 8 Next

How does the showcased collaboration between China and Europe in science and technology contribute to global innovation and address shared challenges?

China's significant investment in R\&D, coupled with its participation in EU's Horizon 2020 program (approximately 300 joint projects), demonstrates a strategic push for global technological leadership. The focus on AI, robotics, and smart mobility reflects priorities for future economic growth and international cooperation.

german.china.org.cn

🌐 85% Global Worthiness

Apr 1, 10:17

Huawei's 2024 Financial Report Shows Strong Growth and Diversification

Huawei reported 2024 revenue of 862.1 billion yuan ($120.1 billion USD), a net profit of 62.6 billion yuan, and invested 179.7 billion yuan in R&D, marking significant growth and diversification into areas such as intelligent automotive solutions and the HarmonyOS ecosystem.

Huawei's 2024 Financial Report Shows Strong Growth and Diversification

Huawei reported 2024 revenue of 862.1 billion yuan ($120.1 billion USD), a net profit of 62.6 billion yuan, and invested 179.7 billion yuan in R&D, marking significant growth and diversification into areas such as intelligent automotive solutions and the HarmonyOS ecosystem.

Progress

52% Bias Score

ShareSaveArticle

Decent Work and Economic Growth

12345678

Previous 1 of 8 Next

What were the key financial results of Huawei in 2024, and what are the immediate implications for the global technology market?

In 2024, Huawei, a Chinese tech giant, reported revenue of 862.1 billion yuan ($120.1 billion USD), a significant increase from the previous year's 704.2 billion yuan. The company also achieved a net profit of 62.6 billion yuan, meeting its projections. This growth is particularly notable given ongoing global economic uncertainty.

thetimes.com

🌐 75% Global Worthiness

Mar 16, 04:09

R&D Spending and Innovation Drive Company Success

Analysis of successful companies reveals a strong correlation between high R&D spending, innovative customer solutions, and financial success, exemplified by Amazon, Alphabet, Microsoft, Novo Nordisk, Eli Lilly, and several AI companies; however, investment in private companies carries significant r...

R&D Spending and Innovation Drive Company Success

Analysis of successful companies reveals a strong correlation between high R&D spending, innovative customer solutions, and financial success, exemplified by Amazon, Alphabet, Microsoft, Novo Nordisk, Eli Lilly, and several AI companies; however, investment in private companies carries significant r...

Progress

44% Bias Score

ShareSaveArticle

Industry, Innovation, and Infrastructure

12345678

Previous 1 of 8 Next

How do successful companies demonstrate innovation to meet customer needs and gain a competitive advantage?

Companies prioritizing R&D, particularly in transformative sectors like AI and healthcare, often exhibit superior long-term growth. This is supported by the success of weight-loss drug developers Novo Nordisk and Eli Lilly, and AI companies like Harvey AI and Perplexity, which are experiencing rapid growth and market share gains.

tr.euronews.com

🌐 55% Global Worthiness

Nov 21, 13:11

Beko to Close Italian Factories, 1,935 Jobs at Risk

Beko Europe announces the closure of two factories in Italy, leading to significant job losses. The company plans to restructure its Italian operations, investing in research and development but impacting 1,935 employees.

Beko to Close Italian Factories, 1,935 Jobs at Risk

Beko Europe announces the closure of two factories in Italy, leading to significant job losses. The company plans to restructure its Italian operations, investing in research and development but impacting 1,935 employees.

Progress

32% Bias Score

ShareSaveArticle

Decent Work and Economic Growth

12345678

Previous 1 of 8 Next

What is the company's plan for its future operations in Italy?

The company cited increased competition from Asian manufacturers and weak demand as reasons for the closures. They plan to invest €110 million in research and development in Italy, creating a center of excellence.

Showing 1 to 10 of 10 results